Acelity competitors

Vivek Jain is a President at CAREFUSION CORP, Board Member at Envista Holdings Corporation, and Chairman/CEO at ICU MEDICAL INC/DE. He has worked as Pres:Medical Tech & Services at CAREFUSION CORP, Pres:Procedural Solutions at CAREFUSION CORP, and Mng Dir/Investment Banker at JPMorgan Chase & Co. Vivek studied at University of Chicago.

Scott Flora has more than 40 years of healthcare experience in surgical devices and is currently serving as Board Chair for Palliare Ltd and New View Surgical. He is also on the Board of Conventus/Flower Orthopaedics. Prior to that Scott held the following leadership roles, Interim President and CEO of Invuity, Executive Director of Conventus Orthopaedics, President and CEO of OmniGuide Surgical, President of Covidien's Surgical Device Group ,President Smith& Nephew Orthopedic Reconstruction, General Manager Smith&Nephew Trauma , Sr. V.P. Sales US and Europe, Global V.P. Sales & Marketing Ioptex Research. Scott has also served on three public company boards, Invuity, MAKO Surgical and Tengion. Scotts skills have been demonstrated in:Building Effective TeamsInnovation ManagementResults OrientedStrategic AgilityBuilding a Strong Vision supported by ValuesGlobal LeadershipCommercial ExecutionGovernance

Mark S Ordan is a Chief Executive Officer at MEDNAX INC, Board Member at Chamber Of Commerce Of The United States Of America, and Board Member at Fidelity & Trust Bank. He has experience at Goldman Sachs and has worked as Board Member at WASHINGTON PRIME GROUP INC., President/CEO at MILLS CORP, and Trustee at Federal Realty Invsmt Trust. Mark works or has worked as BOARD MEMBER at International Center for Research on Women, BOARD MEMBER at The Economic Club of Washington DC, and BOARD MEMBER at Seed Capital. He studied at Vassar College and Harvard Business School.

Chris Barry serves as the chief executive officer and a member of the NuVasive Board of Directors. Prior to this role, Mr. Barry served as senior vice president and president of surgical innovations, the second largest business unit at Medtronic with $5.5 billion in annual revenue, from 2015 to 2018. In this role, Chris provided strategic direction to more than 14,000 employees working in 78 countries, including 10 manufacturing sites and multiple R&D centers. Prior to the acquisition of Covidien by Medtronic, Mr. Barry was president, Advanced Surgical Technologies of Covidien, where he led global strategy, product portfolio and U.S. commercial teams for the $3.2 billion global business unit. Mr. Barry spent more than 15 years in increasing commercial and executive leadership roles at Covidien. Mr. Barry received a bachelor’s degree in environmental science from Texas Tech University.

Ed was named president & chief executive officer of Owens & Minor, effective March 7, 2019, and was appointed to the board of directors at the same time. Prior to that, Ed served as an independent consultant and advisor in the healthcare, life science and distribution industries since January 2016. From January 2000 through April 2015, he served in various roles of increasing responsibility at Thermo Fisher Scientific, a $17 billion manufacturer and supplier of a range of products to the research, healthcare, industrial and safety markets, including most recently as chief commercial officer & senior vice president. Before joining Thermo Fisher Scientific, Ed spent eight years at TRW Inc., in a variety of finance roles and three years with PricewaterhouseCoopers as an auditor.

Kevin serves as the fifth Chairman and CEO at Stryker since it was founded in 1941 by Dr. Homer Stryker, an orthopaedic surgeon. Stryker is a leading medical technology company with over 40,000 employees. Kevin was born in India, grew up in Canada, and has lived and worked in four countries and four industries. He is the current chair of AdvaMed (Med-Tech trade association) and is a member of the Business Roundtable and Business Council. He is also active with community boards.

Ronald A. Rittenmeyer has served as a director of IQVIA since October 2016. Prior to this, Mr. Rittenmeyer served as a Director of IMS Health from April 2010 to October 2016. He served as Chairman, President and CEO of Expert Global Solutions, Inc. from 2008 to June 2014. Prior to that, Mr. Rittenmeyer served as Chairman, CEO and President of Electronic Data Systems Corporation from 2005 until 2008.He served as Chief Operating Officer of Electronic Data Systems Corporation from October 2005 until September 2007 (including service as Co-Chief Operating Officer until May 2006) and as Executive Vice President, Global Service Delivery from July 2005 until December 2006. Mr. Rittenmeyer also serves on the boards of directors of American International Group, Inc. and Tenet Health Care Corporation. He previously served as a director of EDS and RH Donnelley (presently Dex One Corporation). Mr. Rittenmeyer has a bachelor of arts degree in Commerce and Economics from Wilkes University, and his MBA from Rockhurst University. Mr. Rittenmeyer chairs the Leadership Development and Compensation Committee and serves as a member of the Audit Committee.

As chief executive officer and member of the board of directors, Joe Woody brings 20 years of healthcare leadership and medical technology expertise to Avanos. Under Joe’s leadership, Avanos has successfully executed its transformation into a focused medical devices business, with a clear strategy to achieve category leadership in its core Pain Management and Chronic Care divisions. Avanos is focused on delivering clinically superior breakthrough solutions that will help patients get back to the things that matter. The company is committed to creating the next generation of innovative healthcare solutions, which will address our most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery.

Bobbie Haagensen is a Regional Chief Executive, Southeast Asia at BEA Systems and is based in Laramie, Wyoming.